Gilead Announces Clinical Trial For An Inhaled Version Of Remdesivir

Gilead Announces Clinical Trial For An Inhaled Version Of Remdesivir

Assessment

Interactive Video

Biology, Health Sciences

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses trials for an inhaled version of Ram Dass as a potential COVID-19 treatment. Currently administered intravenously, the drug received FDA emergency use authorization in May. Gilead plans to conduct further trials, including outpatient settings, to make administration easier and potentially more effective. The announcement led to a drop in Gilead's stock price.

Read more

2 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What is the current method of administering the antiviral drug to COVID-19 patients?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

What was the market reaction to Gilliad's announcement regarding the inhaled version of the drug?

Evaluate responses using AI:

OFF